SEVERE WX : High Wind Warning - Wind Advisory View Alerts
STREAMING NOW: Watch Now

Congress investigates lifting some cannabis restrictions

Cannabis continues to make history on Capitol Hill — albeit incrementally.Although federal cannabis legalization may not be imminent, Congress is ta...

Posted: Jan 15, 2020 6:22 PM

Cannabis continues to make history on Capitol Hill — albeit incrementally.

Although federal cannabis legalization may not be imminent, Congress is taking early steps to better understand how to research and regulate the complex plant.

The Health subcommittee of the US House Committee on Energy and Commerce on Wednesday joined the shortlist of subcommittees that have delved into cannabis. No votes were cast nor policy decisions made, but the 3 1/2-hour hearing — the first-ever cannabis hearing for the Energy and Commerce committee — provided windows into legislators' temperatures on cannabis legalization and the actions undertaken to-date by a trio of government agencies wielding significant influence over how cannabis is researched, possessed and consumed.

Serving as the backdrop for the "Cannabis Policies for the New Decade" hearing is a quasi post-Prohibition landscape where 11 states have legalized the sale and possession of cannabis for adult-use and 22 others have medical cannabis laws in place. At the same time, cannabis remains illegal federally, creating a rash of conflicts and complications in areas such as research, banking, taxes and commerce.

"The states are way ahead of where we are federally," Representative Greg Walden, a Republican from Oregon, which launched adult-use cannabis sales in 2015, a year after Colorado and Washington state started their recreational cannabis programs.

During Wednesday's hearing, legislators took a crack at cannabis' chicken-and-egg problem: Cannabis remains a Schedule I substance -- the most restrictive class and identified as having no medical use -- because of a lack of comprehensive research. Research, however, is hindered because of the Schedule I classification. Officials from the US Food and Drug Administration, the US Drug Enforcement Administration and the National Institutes of Health provided testimony.

"The federal government has hidden behind that Catch-22 for a long, long time," said Representative Joe Kennedy III, a Democrat from Massachusetts.

The University of Mississippi remains the sole supplier of research-grade cannabis for federally approved trials. And the cannabis that's available for research has been assailed by scientists as "sub-par" material that does not accurately represent the diverse array of products — and potencies — available for sale in states that have legalized recreational cannabis.

Matthew Strait, senior policy adviser for the DEA's Diversion Control Division, said the agency has sought to remove barriers to research and is moving "expeditiously" to craft additional regulations and expand the number of licensed cultivators.

The FDA's ongoing review of the wildly popular cannabis compound cannabidiol (CBD) remains ongoing, said Dr. Douglas Throckmorton, deputy director for regulatory programs at the FDA's Center for Drug Evaluation of Research. He indicated his agency is evaluating research to determine CBD's safety and efficacy, weighing non-drug pathways for compounds derived from federally legal hemp, and creating avenues for new drug development involving cannabis compounds.

"We're looking at a full range of options," he said.

During their questioning, subcommittee members referenced several of the active cannabis-related bills before Congress, and asked if rescheduling or even descheduling cannabis would solve some of these ongoing conflicts.

Descheduling cannabis may indeed accelerate research, said Dr. Nora Volkow, director of the NIH's National Institute on Drug Abuse.

However, she quickly cautioned that doing so "may have unintended, negative consequences," including decreased perceptions of risk and potential harms to health.

Oregon Coronavirus Cases

Data is updated nightly.

Cases: 156287

Reported Deaths: 2252
CountyCasesDeaths
Multnomah31935542
Washington21311212
Marion18541285
Clackamas13426183
Lane10325129
Jackson8489114
Umatilla767882
Deschutes597561
Yamhill379168
Linn360157
Malheur335358
Polk307343
Klamath279855
Douglas252755
Josephine236553
Benton234817
Jefferson196628
Coos152420
Union129519
Columbia127421
Wasco122126
Lincoln113620
Hood River106929
Morrow104914
Clatsop7776
Crook77618
Baker6639
Curry4296
Tillamook4212
Lake3786
Harney2776
Grant2251
Wallowa1425
Gilliam541
Sherman530
Wheeler221
Unassigned00

California Coronavirus Cases

Data is updated nightly.

Cases: 3582320

Reported Deaths: 53083
CountyCasesDeaths
Los Angeles119601721676
Riverside2904983849
San Bernardino2870552959
Orange2617983966
San Diego2613533342
Santa Clara1110761798
Kern103756915
Fresno957851451
Sacramento937901498
Alameda809501271
Ventura77952870
San Joaquin671231150
Contra Costa62931695
Stanislaus56433953
Tulare48114768
Monterey42335329
San Mateo39148521
San Francisco34387422
Santa Barbara32147420
Solano30216165
Merced29264407
Sonoma28261301
Imperial26926638
Kings22091220
Placer19911232
San Luis Obispo19751238
Madera15523214
Santa Cruz14736183
Marin13285198
Yolo12867185
Shasta11054179
Butte11007167
El Dorado9195100
Napa908072
Sutter889998
Yuba577638
San Benito577061
Lassen562324
Tehama510452
Nevada398874
Tuolumne396659
Mendocino382643
Amador347441
Humboldt323033
Lake316941
Glenn223223
Colusa214013
Calaveras191849
Siskiyou178414
Inyo132137
Mono12144
Del Norte10085
Plumas6536
Modoc4604
Mariposa3957
Trinity3735
Sierra1000
Alpine820
Unassigned00
Medford
Clear
54° wxIcon
Hi: 65° Lo: 34°
Feels Like: 54°
Brookings
Partly Cloudy
53° wxIcon
Hi: 56° Lo: 39°
Feels Like: 53°
Medford
Partly Cloudy
54° wxIcon
Hi: 44° Lo: 22°
Feels Like: 54°
Medford
Partly Cloudy
54° wxIcon
Hi: 65° Lo: 32°
Feels Like: 54°
Klamath Falls
Partly Cloudy
51° wxIcon
Hi: 50° Lo: 30°
Feels Like: 51°
Strong south winds Thursday
KDRV Radar
KDRV Fire Danger
KDRV Weather Cam

Community Events